Redeye growth day

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics

Idiopathic Pulmonary Fibrosis: 5 Things to Know

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Patient insights to shape development of a dCBT for IPF patients